Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ruxolitinib Cream in Children Aged 2-11 Years With Non-segmental Vitiligo: A Single-Center, Real-World Study

NCT07595939 is registered in ClinicalTrials.gov with The Children's Hospital of Zhejiang University School of Medicine as lead sponsor.

NCT NCT07595939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ruxolitinib Cream in Children Aged 2-11 Years With Non-segmental Vitiligo: A Single-Center, Real-World Study
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo